Lyvispah Interactions
There are 365 drugs known to interact with Lyvispah (baclofen), along with 4 disease interactions, and 1 alcohol/food interaction. Of the total drug interactions, 27 are major, 337 are moderate, and 1 is minor.
- View all 365 medications that may interact with Lyvispah
- View Lyvispah alcohol/food interactions (1)
- View Lyvispah disease interactions (4)
Most frequently checked interactions
View interaction reports for Lyvispah (baclofen) and the medicines listed below.
- Adderall (amphetamine / dextroamphetamine)
- Airborne (multivitamin with minerals)
- albuterol
- Astepro (azelastine nasal)
- Atripla (efavirenz / emtricitabine / tenofovir)
- azithromycin
- cefdinir
- Centrum (multivitamin with minerals)
- cyclobenzaprine
- dantrolene
- diphenhydramine
- doxycycline
- Eprontia (topiramate)
- fenofibrate
- furosemide
- guaifenesin
- levetiracetam
- levofloxacin
- loratadine
- metformin
- minocycline
- mometasone topical
- montelukast
- Mounjaro (tirzepatide)
- Mucinex (guaifenesin)
- Nexium 24HR (esomeprazole)
- Novolog (insulin aspart)
- Pedialyte (electrolyte replacement solutions)
- polyethylene glycol 3350
- prednisone
Lyvispah alcohol/food interactions
There is 1 alcohol/food interaction with Lyvispah (baclofen).
Lyvispah disease interactions
There are 4 disease interactions with Lyvispah (baclofen) which include:
More about Lyvispah (baclofen)
- Lyvispah consumer information
- Compare alternatives
- Pricing & coupons
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: skeletal muscle relaxants
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.